U.S. Healthcare Services Stock News

Blue Owl Capital (OWL) recently issued US$400 million of 6.300% unsecured notes due 2031, giving the company fresh funding to refinance existing debt and adjust its overall capital structure. See our latest analysis for Blue Owl Capital. The notes issue comes as Blue Owl Capital’s share price sits at US$10.06, with the stock up 9.59% on a 1 month share price return but down 34.29% year to date. The 3 year total shareholder return of 16.60% contrasts with a 1 year total shareholder return that...

In May 2026, XP Inc. announced past first-quarter 2026 results showing higher revenue and net income year on year, alongside a new cash dividend of US$0.20 per Class A share and approval of a fresh share repurchase program of up to R$1.00 billion. XP also set in motion a planned CFO succession and interim arrangement while continuing buybacks under its prior program, signaling an emphasis on capital returns and financial leadership continuity. We’ll now examine how the newly approved...

In May 2026, a Delaware jury found Cummins liable for misappropriating C3 AI’s trade secrets, while the company also filed a multibillion-dollar shelf registration, maintained its quarterly US$2.00 dividend, and reported shareholder votes rejecting proposals on board leadership structure and charitable giving disclosure. This combination of legal setbacks, governance debates, and fresh capital-raising capacity adds new context to Cummins’ efforts to balance growth ambitions with risk...

FB Financial (FBK) is drawing attention after recent share moves, with the stock up around 2.7% over the past week but down over the past month and the past three months. See our latest analysis for FB Financial. The recent 7 day share price return of 2.7% comes after weaker momentum earlier in the year, with the year to date share price return down 6.1% even as the 1 year total shareholder return is 22.6%. If FB Financial's recent moves have you thinking about what else might be setting up...

Earlier in May 2026, Zai Lab announced the departure of President and COO Josh Smiley as part of a leadership reshuffle to improve operational efficiency, while continuing preparations for key product launches and clinical milestones. A few days earlier, the company had reported FDA Fast Track Designation for its investigational DLL3-targeting ADC zoci in extrapulmonary neuroendocrine carcinomas, highlighting progress in a cancer area with no established targeted options. We’ll now examine...

In recent days, Nutanix has faced mixed signals as analysts projected quarterly earnings of US$0.35 per share on US$686.02 million in revenue, while investors reacted to a private share issuance to AMD and a cautious outlook tied to macroeconomic uncertainty. Amid these cross‑currents, some research platforms argue Nutanix’s shares trade below certain intrinsic value estimates even as analysts highlight strong recurring revenue trends alongside concerns about dilution and short‑term...

Warner Music Group (WMG) is back in focus after reporting Q1 revenue growth of 16.7% year on year, beating analyst expectations by 7.5% and lifting the stock 11.6% since the release. See our latest analysis for Warner Music Group. The recent Q1 beat has come on top of strong momentum, with a 30 day share price return of 19.97% and a 1 year total shareholder return of 35.85%. This has signaled improving sentiment around Warner Music Group. If solid execution at Warner Music Group has caught...

Earlier this week, EZCORP director Matthew W. Appel sold 15,037 Class A Non-Voting Common Stock shares on 20 May 2026 at US$33.25 each, and still directly holds 124,975 shares in the company. Around the same time, EZCORP was upgraded to a Zacks Rank #1 (Strong Buy) on the back of rising earnings estimates and a more optimistic analyst outlook for its underlying business. We’ll now explore how the Zacks earnings-driven upgrade interacts with EZCORP’s existing turnaround narrative and expected...

Marcus & Millichap (MMI) recently appointed commercial real estate veteran Michael Puline as senior managing director and national director of its retail division, placing new leadership over the company’s retail advisory and execution platform. See our latest analysis for Marcus & Millichap. The executive hire comes as the stock trades at US$28.83, with a 90 day share price return of 10.63% and a 1 year total shareholder return of 4.36%, pointing to gradually improving momentum after weaker...

Hut 8 (HUT) is in focus after committing about US$16 million to expand the local water system in West Feliciana Parish, Louisiana, in connection with its planned River Bend AI data center campus. See our latest analysis for Hut 8. The current US$105.9 share price sits against a very strong recent run, with a 30 day share price return of 37.77% and a year to date share price return of 106.55%. The 1 year total shareholder return is very large at about 7x, which suggests that investors are...

In the past quarter, Regal Rexnord reported revenue of US$1.48 billion, beating analyst expectations and citing an 8.5% rise in enterprise daily orders, with Automation & Motion Control orders up more than 34% on demand from aerospace, defense, data center, and medical customers. Alongside this operational strength, the company highlighted ongoing resilience in commercial HVAC and improving industrial powertrain orders, underscoring how data center and automation projects are increasingly...

PJT Partners (PJT) has drawn investor interest after recent share price moves, with the stock closing at US$156.56. The company focuses on advisory services across mergers, restructurings, capital markets and private fund placements. See our latest analysis for PJT Partners. Recent share price moves sit against a mixed backdrop, with a 4.32% 90 day share price return and a decline of 7.66% year to date, while the 3 year total shareholder return is 137.90%, suggesting long term momentum has...

Annaly Capital Management recently reported past first-quarter 2026 earnings of US$0.76 per share, surpassing estimates while improving net interest margins, book value per share, and ending the period with about US$9.00 billion in financing-ready assets. The company underscored its income-focused appeal by supporting a US$0.70 quarterly dividend with earnings, authorizing a US$1.50 billion share repurchase program through 2029, and raising US$509.00 million via its at-the-market equity...

Earlier this month, Herbalife reported past Q1 adjusted EPS of US$0.64, topping consensus expectations, with year-on-year revenue growth and completion of a debt refinancing, while also launching its global “Fuel Like Ronaldo” nutrition campaign. Management highlighted progress in personalization capabilities and faster product rollout, suggesting its wellness platform ambitions are becoming more embedded in day-to-day execution. Next, we’ll examine how Herbalife’s earnings beat and...

ZTO Express (Cayman) Inc. recently reported first-quarter 2026 results, with sales rising to C¥13,282.36 million and net income reaching C¥2,118.33 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. The company also disclosed the resignation of non-executive director Ms. Di Xu following the termination of an investor rights agreement with Alibaba Group subsidiaries, a governance change that may influence perceptions of ZTO’s...

Earlier in 2026, BrightSpring Health Services held its Annual Meeting of Stockholders, electing three Class II directors through 2029, ratifying KPMG as auditor for 2026, and securing shareholder approval for its executive compensation program. A separate update highlighted that, since its Nasdaq debut in January 2024, BrightSpring’s shares have risen by a very large amount alongside increased full-year 2026 revenue and adjusted EBITDA guidance following robust quarterly results. Now we’ll...

Parsons Corporation recently served as lead designer for Los Angeles Metro’s D Line Subway Extension Section 1, now open and adding 3.9 miles of rail and three new underground stations between Wilshire/Western and Beverly Hills, while also securing a new US$136 million-ceiling architect-engineer contract at Hill Air Force Base. These projects highlight Parsons’ role in complex transit and defense infrastructure, expanding its visibility across urban mobility, cultural access, and long-term...

Earlier this month, GEO Group reported first-quarter results showing a 16.6% year-on-year revenue increase, beating analyst expectations and prompting management to raise full-year guidance. The combination of stronger-than-expected earnings, an upgraded outlook, and improving business services demand highlights how GEO Group is benefiting from shifting security and detention needs amid easing geopolitical risks. Next, we’ll examine how this upgraded full-year guidance and earnings strength...

Viking Holdings (VIK) is back in focus after first quarter results showed higher revenue, improved operating margins, and increased passenger volumes, alongside strong 2026 bookings and an analyst upgrade highlighting potential yield growth. See our latest analysis for Viking Holdings. The first quarter update and leadership changes have come against a backdrop of solid momentum, with a year to date share price return of 16.55% and a 1 year total shareholder return of 92.44%, suggesting...

In May 2026, Wolverine World Wide reported first-quarter 2026 results showing sales of US$457.6 million and net income of US$20.2 million, alongside raising its full-year 2026 earnings guidance while keeping revenue expectations of about US$1.96 billion to US$1.99 billion unchanged. Alongside this earnings upgrade, shareholders voted against a proposed new climate policy, highlighting a gap between parts of the investor base and current board-level priorities on sustainability. Next, we will...

What recent performance suggests about GeneDx Holdings GeneDx Holdings (WGS) has drawn attention after a mixed run in its stock, with the price roughly flat over the past day, up about 16% over the past week, yet down over the past month and past 3 months. See our latest analysis for GeneDx Holdings. Looking beyond the recent bounce, the stock has a 7-day share price return of 16.1%, but the 30-day and year to date share price returns are down 31.0% and 64.2% respectively, while the 3-year...

CME Group (CME) has drawn investor interest after recent trading in the stock, with a last close of $291.23 and a market value of about $105.5b, prompting a closer look at fundamentals. See our latest analysis for CME Group. Recent trading has been choppy, with the 7 day share price return down 4.55% and the 90 day share price return down 8.71%. However, the year to date share price return of 7.99% and a 3 year total shareholder return of 87.62% still point to longer term momentum. If CME...

NCR Atleos has expanded its Cashzone ATM network into Colombia, partnering with Bancoomeva as sponsoring and settlement bank to provide compliant, reliable cash access nationwide. This move extends Cashzone’s presence to 14 countries and reinforces NCR Atleos’ role in supporting financial inclusion where both cash and digital payments remain important. Next, we’ll explore how this Colombia expansion, supported by Bancoomeva and aligned with Asobancaria’s priorities, may influence NCR Atleos’...

Recent performance context for Spyre Therapeutics (SYRE) Spyre Therapeutics (SYRE) has drawn increased attention after a strong stock performance over the past 3 months and year to date, prompting investors to reassess what the current price implies. See our latest analysis for Spyre Therapeutics. The recent surge, including a 70.43% 90 day share price return and very large 3 year total shareholder return, points to strong momentum, even though the latest 1 day move was slightly weaker. If...